Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

SHA:603567 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 29, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	10,070	11,423	11,988	14,412	9,477	10,818
Market Cap Growth	-2.67%	-4.71%	-16.82%	52.08%	-12.40%	6.34%
Enterprise Value	12,940	13,636	13,478	17,271	11,076	11,034
Last Close Price	10.72	11.94	12.50	14.86	10.84	12.15
PE Ratio	15.45	24.16	64.65	43.40	21.72	26.47
Forward PE	-	36.69	36.69	36.69	36.69	36.69
PS Ratio	3.23	3.64	2.85	3.49	2.78	3.29
PB Ratio	1.22	1.42	1.69	2.04	1.72	2.06
P/TBV Ratio	1.45	1.69	1.90	2.12	1.80	2.17
P/FCF Ratio	-	-	-	-	-	256.74
P/OCF Ratio	-	-	-	-	61.07	48.97
EV/Sales Ratio	4.15	4.35	3.20	4.18	3.25	3.35
EV/EBITDA Ratio	14.54	38.07	-	42.55	14.94	15.66
EV/EBIT Ratio	18.64	73.50	-	63.88	18.92	19.48
EV/FCF Ratio	-43.54	-	-	-	-	261.86
Debt / Equity Ratio	0.41	0.39	0.41	0.42	0.58	0.51
Debt / EBITDA Ratio	3.79	8.52	-	7.23	4.33	3.81
Debt / FCF Ratio	-	-	-	-	-	63.74
Asset Turnover	0.26	0.26	0.36	0.38	0.35	0.38
Inventory Turnover	1.46	2.14	4.07	3.34	1.80	1.43
Quick Ratio	2.08	2.16	1.27	2.04	1.92	2.02
Current Ratio	2.69	2.60	1.65	2.37	2.66	2.40
Return on Equity (ROE)	8.31%	6.17%	2.70%	5.30%	8.14%	7.93%
Return on Assets (ROA)	3.55%	0.96%	-1.17%	1.55%	3.80%	4.12%
Return on Capital (ROIC)	3.90%	1.09%	-1.35%	1.81%	4.40%	4.70%
Return on Capital Employed (ROCE)	6.90%	1.90%	-	3.10%	7.30%	8.60%
Earnings Yield	6.49%	4.14%	1.55%	2.30%	4.60%	3.78%
FCF Yield	-2.95%	-5.02%	-6.10%	-6.12%	-7.53%	0.39%
Dividend Yield	1.87%	1.68%	0.22%	0.71%	-	1.79%
Payout Ratio	65.74%	33.48%	131.34%	43.28%	76.15%	61.62%
Buyback Yield / Dilution	-0.19%	0.14%	-8.87%	-1.82%	0.01%	0.83%
Total Shareholder Return	1.67%	1.81%	-8.65%	-1.11%	0.01%	2.62%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.